Detection of EBV by EBER-ISH and Histopathology

1. Epstein-Barr Virus (EBV)

1.1. EBV: A Common Virus and Its Transmission

Epstein-Barr virus (EBV) is a member of the herpesvirus family and is highly prevalent worldwide [1]. Most people are infected with EBV at some point in their lives, usually during childhood, often without noticeable symptoms [1]. EBV is primarily transmitted through bodily fluids, particularly saliva. Following infection, the virus can remain latent in the body for life [1].

1.2. The Association Between EBV and Certain Cancers

EBV is recognized as a risk factor for several types of human cancer [2]:

Nasopharyngeal carcinoma: This cancer has the strongest association with EBV, particularly in certain geographic regions [2].
Lymphoma: EBV may be associated with several types of lymphoma, including Hodgkin lymphoma and Burkitt lymphoma [2].
Gastric cancer: EBV is also present in a subset of gastric cancers [2].

2. EBER-ISH: Detecting EBV

What is EBER-ISH?

EBER-ISH (Epstein-Barr virus-encoded RNA in situ hybridization) is a specialized laboratory technique used in pathology. It enables physicians to directly detect viral RNA within cells from a patient's tissue sample. In other words, EBER-ISH helps identify which cells have been infected with EBV.

EBER-ISH is a highly reliable method for detecting the presence of EBV in tissue specimens. It provides important information about the localization and extent of viral infection, including which cell populations within a specific tissue sample harbor the virus.

3. Histopathology: Its Role in Diagnosis

Role of the Department of Pathology: The Department of Pathology is responsible for analyzing tissue and cell samples obtained from the patient's body, such as through biopsy. Pathologists use microscopy and specialized techniques to identify abnormal changes and diagnose diseases, including the presence of infectious agents such as viruses.
Role of Histopathology in EBV Diagnosis: In the diagnosis of EBV-related diseases, particularly cancers, pathology plays a critical role. Pathologists perform EBER-ISH on tissue specimens to detect evidence of EBV. The pathology findings provide an important basis for clinicians to establish the final diagnosis and select the most appropriate treatment for the patient. EBER-ISH also allows EBV to be localized within the histopathological context of the tissue.
When Is EBV or EBER-ISH Testing Needed? When there are abnormal findings such as a mass in the nasopharyngeal region, unexplained enlargement of lymph nodes, or other symptoms suggestive of cancer, a physician may obtain a biopsy and request EBER-ISH testing to determine whether EBV is involved in the underlying disease process [1].

4. Frequently Asked Questions (FAQ)

Is EBER-ISH a blood test? No. EBER-ISH is performed on a tissue sample, usually a biopsy specimen, to detect EBV within cells rather than in blood. Blood tests are generally used to detect EBV antibodies or viral DNA [1].
Does a positive EBER-ISH result mean that I have cancer? A positive EBER-ISH result indicates the presence of EBV in the tissue sample. However, this does not automatically mean that the patient has cancer. The physician will interpret the result together with other clinical and pathological findings to establish an accurate diagnosis.
How can EBV infection be prevented? There is currently no vaccine against EBV [1]. The risk of transmission can be reduced by avoiding close contact with infected individuals and by not sharing food, beverages, or personal items such as toothbrushes [1].

5. References

Centers for Disease Control and Prevention (CDC). (n.d.). About Epstein-Barr Virus (EBV). https://www.cdc.gov/epstein-barr/about/index.html.
Damania, B., Kenney, S. C., & Raab-Traub, N. (2022). Epstein-Barr Virus (EBV): Biology and Clinical Disease. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC9529843/.